跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IN-007
首页
药物
IN-007
IN-007
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
COMPOSITION OF CPG1018/1826/007/2006 IN COMBINATION WITH MNR FOR TREATING PANCREATIC CANCER
WO 2026012340 A1
申请人: YUANBEN ZHUHAI HENGQIN BIOTECHNOLOGY CO LTD
优先权: 2024
CN
WO
2 件公开
COMPOSITIONS AND METHODS FOR TREATING BETA-AMYLOID RELATED DISEASES
US 2011105603 A1
申请人: AMERICAN LIFE SCIENCE PHARMACEUTICALS INC
优先权: 2010
US
2 件公开
EP 3296295 A1
申请人: AMERICAN LIFE SCIENCE PHARMACEUTICALS INC
优先权: 2009
EP
Indole carbazole alkaloid and its preparing method and use
CN 1683374 A
申请人: UNIV CHINA OCEANOLOGY
优先权: 2005
CN
Veterinary medicine composition for treating skin disease of fragrant pig
CN 102342960 A
申请人: UNIV TIANJIN AGRICULTURAL
优先权: 2011
CN
Method for acquiring Nogo-B knockout mode mouse based on CRISPR/Cas9 technology and application thereof
CN 108642090 A
申请人: CHINESE PLA GENERAL HOSPITAL
优先权: 2018
CN
Construction method of mouse with Foxp3 gene knocked out under conditions
CN 111748582 A
申请人: AFFILIATED HOSPITAL QINGDAO UNIV
优先权: 2020
CN
Dendrobium officinale composition as well as preparation method and application thereof
CN 114404525 A
申请人: ZHEJIANG INDUSTRIAL UNIV
优先权: 2022
CN
Composition for reducing uric acid in serum and application thereof
CN 114984060 A
申请人: LIAONING BEIKERUI BIOTECHNOLOGY CO LTD
优先权: 2022
CN
Application of AT-007 in prevention and treatment of androgenetic alopecia
CN 118286223 A
申请人: HANGZHOU THIRD PEOPLES HOSPITAL HANGZHOU HUIMIN HOSPITAL ZHEJIANG UNIV OF TRADITIONAL CHINESE MEDICI
优先权: 2024
CN
SMIC capture antibody, kit and application of sMIC capture antibody
CN 118294656 A
申请人: GUANGZHOU KONCEN BIOTECHNOLOGY CO LTD
优先权: 2024
CN
第 1 / 2 页
上一页
下一页
药物
反馈